Page last updated: 2024-08-17

medroxyprogesterone acetate and Cardiomegaly

medroxyprogesterone acetate has been researched along with Cardiomegaly in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arias-Loza, PA; Bayer, B; Dienesch, C; Ertl, G; Frantz, S; Hu, K; Pelzer, T; Wu, R1
Arias-Loza, PA; Bauersachs, J; Ertl, G; Fritzemeier, KH; Galle, J; Hegele-Hartung, C; Hu, K; Jazbutyte, V; Neyses, L; Pelzer, T; Quaschning, T; Schäfer, A1

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Cardiomegaly

ArticleYear
Medroxyprogesterone acetate aggravates oxidative stress and left ventricular dysfunction in rats with chronic myocardial infarction.
    Toxicologic pathology, 2011, Volume: 39, Issue:5

    Topics: Analysis of Variance; Animals; Blood Pressure; Cardiomegaly; Chronic Disease; Electrocardiography; Estradiol; Female; Heart Rate; Histocytochemistry; Medroxyprogesterone Acetate; Myocardial Infarction; NADPH Oxidases; Ovariectomy; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Ventricular Dysfunction, Left; Ventricular Remodeling

2011
Medroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 48, Issue:5

    Topics: Aldosterone; Androstenes; Animals; Cardiomegaly; Cardiovascular System; Collagen; Estradiol; Estrogen Antagonists; Female; Medroxyprogesterone Acetate; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Rats; Rats, Wistar; Salts

2006